KEY POINTS:
Biotechnology company A2 posted an annual loss of $5.08 million, around four times greater than the previous year, in part due to the cost of expansion in the United States.
Revenue rose to $7.6 million for the year ended March, largely on the back of income from the company's Australian subsidiary. However, A2 Australia also contributed to increased operating costs.
